- ►touchcardiology.com [PDF] T Mazzone, PM Meyer, SB Feinstein, MH … - Jama, 2006 - Am Med Assoc Context Carotid artery intima-media thickness (CIMT) is a marker of coronary
atherosclerosis and independently predicts cardiovascular events, which are
increased in type 2 diabetes mellitus (DM). While studies of relatively ... Cited by 216 - Related articles - BL Direct - All 13 versions
- ►ahajournals.org CP Liang, S Han, T Senokuchi, AR Tall - Circulation research, 2007 - Am Heart Assoc The macrophage has emerged as an important player in the pathogenesis of both
atherosclerosis and insulin resistance. Cross-talk between inflammatory
macrophages and adipocytes may be involved in insulin resistance in ... Cited by 43 - Related articles - All 6 versions
- ►ahajournals.org M Davidson, PM Meyer, S Haffner, S … - Circulation, 2008 - Am Heart Assoc From the Pritzker School of Medicine (MD), The University of Chicago, Chicago,
Ill; Department of Preventive Medicine (PMM, ZC) and Department of Medicine,
Section of Cardiology (SF), Rush University Medical Center, Chicago, Ill; ... Cited by 22 - Related articles - All 6 versions
HE Bays, RB Goldberg - American Journal of Therapeutics, 2007 - journals.lww.com Over 30 years ago, bile acid sequestrants (BAS) were among the first drugs
approved to lower cholesterol levels. For over 10 years, BAS have been known to
reduce glucose levels. Most importantly, BAS have been shown in outcomes ... Cited by 14 - Related articles - BL Direct - All 4 versions
- ►onlinejacc.org JA Lindenfeld, FA Masoudi - Journal of the American College of Cardiology, 2007 - Elsevier Thiazolidinediones (TZDs) effectively improve glycemic control in patients with
type 2 diabetes mellitus (T2DM) when used alone or in combination with other
hypoglycemic agents (10). The insulin-sensitizing effects of TZDs are ... Cited by 7 - Related articles - BL Direct - All 12 versions
- ►nih.gov AH Xiang, HN Hodis, M Kawakubo, RK Peters, … - Atherosclerosis, 2008 - Elsevier The Pioglitazone in the Prevention of Diabetes (PIPOD) study was a single arm
3-year open-label pioglitazone treatment to determine the effects of
pioglitazone in women with prior gestational diabetes mellitus (GDM) who ... Cited by 6 - Related articles - All 18 versions
TH Schindler, AD Facta, JO Prior, J Cadenas, … - European Journal of Nuclear Medicine and Molecular …, 2009 - Springer Page 1. ORIGINAL ARTICLE Structural alterations of the coronary arterial wall are
associated with myocardial flow heterogeneity in type 2 diabetes mellitus ... Cited by 5 - Related articles - All 2 versions
F Gizard, D Bruemmer - PPARs/RXRs in Cardiovascular Physiology and … - hindawi.com Page 1. Hindawi Publishing Corporation PPAR Research Volume 2008, Article
ID 429123, 11 pages doi:10.1155/2008/429123 Review Article ... Cited by 2 - Related articles - View as HTML - All 15 versions
- ►ucs.br [PDF] EM Lonn, HC Gerstein, P Sheridan, S Smith, … - Journal of the American College of Cardiology, 2009 - Elsevier One thousand four hundred twenty-five people with IGT and/or IFG but without
cardiovascular disease or diabetes were randomized to ramipril 15 mg/day or its
placebo and to rosiglitazone 8 mg/day or its placebo with a 2 × 2 ... Cited by 2 - Related articles - All 24 versions
R Chen, F Liang, J Moriya, J Yamakawa, T … - International Journal of Cardiology, 2008 - Elsevier Peroxisome proliferator-activated receptors (PPARs) α and γ regulate nearly
every step in cellular fatty acid uptake, utilization, oxidation, and storage
pathways. They also control cell growth and migration, oxidative stress, ... Cited by 3 - Related articles - All 25 versions
